HKSE - Delayed Quote HKD

Innovative Pharmaceutical Biotech Limited (0399.HK)

0.199 0.000 (0.00%)
At close: April 26 at 3:55 PM GMT+8
Key Events
Loading Chart for 0399.HK
DELL
  • Previous Close 0.199
  • Open 0.193
  • Bid 0.193 x --
  • Ask 0.199 x --
  • Day's Range 0.193 - 0.199
  • 52 Week Range 0.190 - 0.370
  • Volume 205,000
  • Avg. Volume 67,061
  • Market Cap (intraday) 342.915M
  • Beta (5Y Monthly) -0.12
  • PE Ratio (TTM) --
  • EPS (TTM) -0.110
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Innovative Pharmaceutical Biotech Limited, an investment holding company, engages in the trading of beauty equipment and products in the People's Republic of China and Hong Kong. The company operates in two segments, Trading of Beauty Products, and Research and Development. It is also involved in the securities investment; research, development, and commercialization of oral insulin products; distribution of bio-industrial products; healthcare management; and provision of genetic testing services. The company was formerly known as United Gene High-Tech Group Limited and changed its name to Innovative Pharmaceutical Biotech Limited in September 2015. Innovative Pharmaceutical Biotech Limited is headquartered in Sheung Wan, Hong Kong.

www.ipb.asia/en/global/home.php

20

Full Time Employees

March 31

Fiscal Year Ends

Related News

Performance Overview: 0399.HK

Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

0399.HK
9.13%
HANG SENG INDEX
3.54%

1-Year Return

0399.HK
1.97%
HANG SENG INDEX
10.03%

3-Year Return

0399.HK
19.76%
HANG SENG INDEX
39.30%

5-Year Return

0399.HK
46.22%
HANG SENG INDEX
40.27%

Compare To: 0399.HK

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 0399.HK

Valuation Measures

Annual
As of 4/26/2024
  • Market Cap

    342.92M

  • Enterprise Value

    1.34B

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    41.73

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    174.56

  • Enterprise Value/EBITDA

    4.30

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    830.52%

  • Return on Assets (ttm)

    -0.88%

  • Return on Equity (ttm)

    18.42%

  • Revenue (ttm)

    7.66M

  • Net Income Avi to Common (ttm)

    63.65M

  • Diluted EPS (ttm)

    -0.110

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    862k

  • Total Debt/Equity (mrq)

    312.72%

  • Levered Free Cash Flow (ttm)

    -168.82M

Company Insights: 0399.HK

People Also Watch